Latest news and events

December 6, 2025

Aitiologic Takes on Preeclampsia: Preparing for Large-Scale Validation after Presentation of Feasibility Study at FMF Conference in London

Aitiologic's Chief Medical Officer, Dr. Rebecca Ertl, presented the first feasibility results of the aitios® platform for tissue-specific liquid biopsy to over 1,500 clinicians and researchers.

October 4, 2024

Aitiologic developing liquid biopsy platform assay for tissue-of-origin analysis, early disease detection

Precision medicine startup Aitiologic is developing a liquid biopsy assay and analysis platform that hopes to enable early disease detection by harnessing both the genetic and epigenetic signatures of cell-free DNA from blood samples.

FMF Advances Course 2026

Meet us at the FMF Advances Course in London to discuss current clinical and research advances in fetal medicine.

23rd World Congress in Fetal Medicine

Meet us at the 23rd World Congress in Fetal Medicine in Vienna to discuss prenatal screening, fetal medicine, and precision diagnostics.

Austrian Life Science Day 2026

Meet us at Austrian Life Science Day 2026 in Vienna to discuss clinical evidence, diagnostics, and development pathways with Austria's life science community.

HLTH Europe

Meet us at HLTH Europe in Amsterdam to discuss precision medicine, AI-enabled diagnostics, and partnerships across the healthcare innovation ecosystem.

bio:cap Europe

Meet us at bio:cap Europe in Berlin for focused conversations with investors, industry partners, and founders working across biotechnology, TechBio, diagnostics, and AI.

LSX World Congress Europe

Aitiologic attended LSX World Congress Europe in Lisbon to meet investors and partners focused on life science company building and financing.

BIO-Europe Spring

Aitiologic attended BIO-Europe Spring in Lisbon for partnering meetings with biotech, pharma, and investor stakeholders across the global life science community.

DxPx Europe '26

Aitiologic attended DxPx Europe in Munich to discuss diagnostics, precision medicine, and financing opportunities with industry and investment partners.

JPM 44th Annual Healthcare Conference

Aitiologic attended the JPM Healthcare Conference in San Francisco, where Chief Executive Officer Dr. Andreas Posch presented in the Biotech Seed Showcase Track.

FMF Advances Course

Aitiologic presented at the FMF Advances Course in London, where Chief Medical Officer Dr. med. Rebecca Ertl shared research on multi-modal cfDNA profiling for preeclampsia prevention.

14th CNAPS International Symposium

Aitiologic attended the 14th CNAPS International Symposium in Hong Kong to engage with the circulating nucleic acids research community and discuss emerging diagnostic applications.

BIO-Europe

Aitiologic attended BIO-Europe in Vienna for partnering meetings across the biotechnology and life science ecosystem.

29th International Conference on Prenatal Diagnosis and Therapy (ISPD)

Aitiologic attended ISPD in Cape Town to engage with the international prenatal diagnosis and therapy community.

International Conference on Newborn Sequencing (ICoNS)

Aitiologic attended ICoNS in New York to engage with the newborn sequencing and genomics community.

28th International Conference on Prenatal Diagnosis and Therapy (ISPD)

Aitiologic attended ISPD in Boston to engage with the prenatal diagnosis and therapy community and follow new clinical and research developments.

Austrian Life Science Day 2024

Aitiologic attended Austrian Life Science Day in Graz to connect with the Austrian life science community around health data and innovation.

13th International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS)

Aitiologic attended CNAPS 2024 in Graz to discuss advances in circulating nucleic acids, cfDNA biology, and molecular diagnostics.

Symposium on Prä- und postnatale Genetik für Geburtshilfe und Kinderheilkunde

Aitiologic attended the Medical University of Vienna symposium on prenatal and postnatal genetics to engage with developments in genetic diagnostics and care.

Biotech Summit Austria

Aitiologic attended Biotech Summit Austria in Graz to connect with Austrian and international biotechnology stakeholders.